Andrea Tan
Stock Analyst at Goldman Sachs
(0.16)
# 3,780
Out of 4,667 analysts
39
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $36 → $41 | $47.39 | -13.49% | 3 | Nov 15, 2024 | |
| INSM Insmed | Maintains: Buy | $74 → $102 | $73.08 | +39.57% | 9 | Jul 10, 2024 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $4.61 | +30.15% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $18.67 | +66.04% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $2.80 | -28.44% | 3 | Jun 5, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $19 → $21 | $8.31 | +152.71% | 4 | Feb 29, 2024 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $50 → $44 | $13.55 | +224.72% | 4 | Feb 27, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $5.84 | -65.75% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $179.04 | -10.63% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $2.75 | +772.73% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $2.04 | +96.56% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $328.57 | +14.13% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $4.65 | +179.57% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $0.77 | +420.22% | 2 | May 24, 2022 |
Tarsus Pharmaceuticals
Nov 15, 2024
Maintains: Neutral
Price Target: $36 → $41
Current: $47.39
Upside: -13.49%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74 → $102
Current: $73.08
Upside: +39.57%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $4.61
Upside: +30.15%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $18.67
Upside: +66.04%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $2.80
Upside: -28.44%
Iovance Biotherapeutics
Feb 29, 2024
Maintains: Buy
Price Target: $19 → $21
Current: $8.31
Upside: +152.71%
Day One Biopharmaceuticals
Feb 27, 2024
Maintains: Buy
Price Target: $50 → $44
Current: $13.55
Upside: +224.72%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $5.84
Upside: -65.75%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $179.04
Upside: -10.63%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $2.75
Upside: +772.73%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $2.04
Upside: +96.56%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $328.57
Upside: +14.13%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $4.65
Upside: +179.57%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $0.77
Upside: +420.22%